STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

Contributed by: Business Wire

Logo

Business Wire logo

Images

STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Graphic: Business Wire)
STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Graphic: Business Wire)
STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Photo: Business Wire)
STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada's Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital. This national awards program recognizes best-in-class Canadian organizations for fostering high-performance corporate cultures that help sustain a competitive advantage. (Photo: Business Wire)
Business Wire embedded0

Tags

General Health
Professional Services
Business
Medical Devices
DEI (Diversity, Equity and Inclusion)
Science
Other Professional Services
Biotechnology
Stem Cells
Human Resources
Health
Consulting
Other Science
STEMCELL Technologies

More Like This

STEMCELL Technologies, Canada’s largest biotechnology company, is releasing its first annual sustainability report. The report, entitled Toward Sustainable Science, provides a comprehensive look at STEMCELL’s environmental, social, and governance performance over the company’s 2023 Fiscal Year (July 1, 2022 through June 30, 2023). (Photo: Business Wire)

STEMCELL Technologies Releases “Toward Sustainable Science” Report

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the opening of its new Canadian sales office at the MaRS Centre, located in the heart of downtown Toronto’s Discovery District. (Photo: Business Wire)

STEMCELL Technologies Expands into Toronto’s MaRS Centre, Grows North American Presence

UST Honored at the 2024 Business Culture Awards

PR Newswire associated0

UST Recognized by Business Culture Awards for the Fourth Consecutive Year

STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Propagenix Inc.—a Maryland-based biotechnology company focused on developing technologies to enable new approaches in regenerative medicine. (Pictured: STEMCELL's headquarters in Vancouver, BC) (Photo: Business Wire)

STEMCELL Technologies Announces Acquisition of Propagenix Inc.

STEMCELL Technologies is pleased to announce the acquisition of substantially all assets of SQZ Biotechnologies Company (SQZ)—a Massachusetts-based biotech known for its game-changing method of introducing a variety of therapeutic cargo into cells by squeezing them (mechanoporation) rather than using electricity (electroporation). This transaction, which was approved by SQZ shareholders on February 29, 2024, marks another significant milestone for STEMCELL, Canada’s largest biotechnology company. (Photo: Business Wire)

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Biotechnologies Company

PR Newswire associated0

UST Wins 10 Brandon Hall 2023 Human Capital Management Excellence Awards

EDITED wins Culture 100 Award. (Graphic: Business Wire)

EDITED™ Wins Culture 100 Award for “The UK’s Greatest Companies to Work For”